Fesoterodine fumarate is a muscarinic acetylcholine receptor antagonist indicated for the treatment of overactive bladder syndrome, where it functions by relaxing the bladder's detrusor muscle. As a prodrug,… Read more



![Chemical structure of (R)-4,4'-[Oxybis(methylene)]bis[2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-phenol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1428856-45-4-R-44-Oxybismethylenebis2-1R-3-bis1-methylethylamino-1-phenylpropyl-phenol.png&w=3840&q=75)













![Chemical structure of [2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4-formylphenyl] isobutyrate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1435768-96-9-2-1R-3-Dipropan-2-ylamino-1-phenylpropyl-4-formylphenyl-isobutyrate.png&w=3840&q=75)
















Fesoterodine fumarate is a muscarinic acetylcholine receptor antagonist indicated for the treatment of overactive bladder syndrome, where it functions by relaxing the bladder's detrusor muscle. As a prodrug, this medication is rapidly de-esterified in the body into its active metabolite. Pharmaceutical laboratories rely on a comprehensive range of Fesoterodine fumarate reference standards, including pharmacopeial and non-pharmacopeial impurities, to ensure drug quality and safety. These high-quality compounds are essential for accurate impurity profiling and method validation throughout the drug development lifecycle. The collection includes various related substances such as degradants, dimers, and stable isotope labelled compounds. By utilizing these precise analytical tools, researchers and quality control analysts can effectively identify and quantify related substances, supporting regulatory compliance and the maintenance of rigorous manufacturing standards for this therapeutic agent.